BIOSYNTEX
LIVE

Serial Number

97422601

Owner

BioSyntex Laboratories, LLC

First Use Date

Aug 4, 2022

Filing Date

May 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIOSYNTEX Trademark

Serial Number: 97422601

BIOSYNTEX is a trademark filed by BioSyntex Laboratories, LLC on May 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

BioSyntex Laboratories, LLC (2 trademarks)

1846 E. Innovation Park Dr., Suite 100
Oro Valley, AZ 85755

Entity Type: 16

Trademark Details

Filing Date

May 21, 2022

Registration Date

Not Registered

First Use Anywhere

August 4, 2022

Goods & Services

Pharmaceutical preparations for medical and scientific research use; pharmaceutical preparations for scientific research; investigational pharmaceutical preparations for clinical and preclinical research use; synthetic peptides for medical use; biological compounds for pharmaceutical research use; drug delivery agents for delivery of pharmaceutical preparations; drug delivery agents in the nature of nanoparticles, liposomes or vesicles for pharmaceutical use; injectable pharmaceutical preparations for research use; transdermal pharmaceutical preparations for research use; implantable pharmaceutical preparations for research use; controlled-release pharmaceutical preparations for research use; pharmaceutical preparations for use in drug discovery and development; pharmaceutical preparations for use in translational medical research; all of the foregoing excluding dietary supplements, nutraceuticals, vitamins, mineral supplements, probiotic preparations, and consumer wellness products.

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2026 CNRT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 30, 2026 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 30, 2026 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 9, 2026 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 29, 2025 RCCK
ASSIGNED TO EXAMINER
Sep 16, 2025 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 25, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 24, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 24, 2024 GNSL
SUSPENSION LETTER WRITTEN
Oct 24, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2024 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 29, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 29, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 29, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2024 CRFA
ASSIGNED TO LIE
Feb 6, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2023 TROA
NOTICE OF REVIVAL - E-MAILED
Sep 14, 2023 NREV
NOTICE OF REVIVAL - E-MAILED
Sep 14, 2023 NREV
PETITION TO REVIVE-GRANTED
Sep 14, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 14, 2023 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 13, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 12, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 12, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2022 NWOS
NEW APPLICATION ENTERED
May 25, 2022 NWAP